Liminal BioSciences Inc reports results for the quarter ended in September - Earnings Summary

Liminal BioSciences

19/11/2021 22:01

* Liminal BioSciences Inc  LMNL.OQ  reported quarterly adjusted
earnings of C$2.74​​ per share for the quarter ended in
September. The mean expectation of two analysts for the quarter
was for a loss of 34 cents per share.
* Revenue fell 73.4% to C$170.00 thousand from a year ago; 
analysts expected C$26.00 thousand. 
* Liminal BioSciences Inc's reported EPS for the quarter was
C$2.74​.
* The mean earnings estimate of analysts was unchanged in the
last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Liminal BioSciences Inc shares had fallen by 37.7% this
quarter and lost 65.7% so far this year.
* The company reported quarterly net income of C$82.26 million.
* Wall Street's median 12-month price target for Liminal
BioSciences Inc is $4.00 
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is no "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell." 
This summary was machine generated November 19 at 10:00 p.m.
 ​All figures in Canadian dollars unless otherwise stated